average weight loss on semaglutide first month Month: What to Expect Semaglutide - Renew Body Wellness

[4] [5] Appropriate clinical management for patients with comorbid metabolic conditions and problematic alcohol use should include: Comprehensive assessment of alcohol consumption patterns using validated screening tools (AUDIT, AUDIT-C) Referral to addiction medicine specialists or behavioral health providers for evidence-based AUD treatment, especially with red flags such as history of severe withdrawal, seizures, delirium tremens, pregnancy, severe liver disease, or suicidality Consideration of FDA-approved pharmacotherapies for alcohol use disorder (naltrexone, acamprosate, disulfiram) with attention to their specific contraindications [9] [11] If GLP-1 therapy is indicated for diabetes or obesity, close monitoring for changes in alcohol consumption and related behaviors Patient education emphasizing that any effects on alcohol cravings are not established therapeutic benefits Regular follow-up to assess medication adherence, adverse effects, and overall treatment response Patients should never discontinue evidence-based treatments for alcohol use disorder in favor of unproven approaches

The same molecule, semaglutide, is FDA-approved specifically for chronic weight management under a different brand, Wegovy

Discounting for money, food, and sex, over the menstrual cycle

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone that regulates metabolism, or how the body uses energy, as previously reported by USA TODAY

If the pattern follows other incretin therapies, weight regain after cessation is likely